DNMT3A and renal cell carcinoma: In addition, DNMT3A was recruited to the promoter region of SLERCC in RCC cells, which induced its hypermethylation, and the DNA methyltransferase inhibitor, 5-AZA, could rescue the reduced expression of SLERCC.